EcoDrugPlus

Ribosomal Protein S3a

Ensembl ID : ENSXMAG00000008099
Gene Symbol: RPS3A
4 Cross references
360 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSXMAG00000014827
Gene Symbol: RPS4X
3 Cross references
495 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSXMAG00000014201
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSXMAG00000002346
Gene Symbol: RPS7
3 Cross references
357 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSXMAG00000014999
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSXMAG00000012175
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSXMAG00000009095
Gene Symbol: RPSA
4 Cross references
515 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSXMAG00000018367
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSXMAG00000015532
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSXMAG00000004922
Gene Symbol: LOC102235904
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Chk2

Ensembl ID : ENSXMAG00000001229
Gene Symbol: LOC102224037
3 Cross references
205 Possible Orthologues:

Serine/threonine-Protein Kinase Pak 4

Ensembl ID : ENSXMAG00000003196
Gene Symbol: LOC102225392
3 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).